Showing results (121-130 of 258) with videos related to
Sort By:
Pageof 26
Cancer Chemotherapy and Pharmacology|April 13, 2011
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II studyPeter Mu-Hsin Chang, Cheng-Hwai Tzeng, Ming-Huang Chen, et al.Lung Cancer (Amsterdam, Netherlands)|December 8, 2024
Sunvozertinib monotherapy in EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancer with EGFR mutationsMengzhao Wang, Yan Xu, Wen-Tsung Huang, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|July 23, 2026
Dynamic 3D imaging system detects vasculogenic mimicry and screens inhibitors in EGFR-mutant lung cancerChun-Hui Lee, Shang-Yin Wu, Wei-Pang Chung, et al.Proteomics. Clinical Applications|February 4, 2020
Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass SpectrometryHsin-Yi Wu, Yu-Yi Pan, Arthur T Kopylov, et al.The Journal of Molecular Diagnostics : JMD|July 23, 2014
Verification of wild-type EGFR status in non-small cell lung carcinomas using a mutant-enriched PCR on selected casesYi-Lin Chen, Cheng-Chan Lu, Shu-Ching Yang, et al.Lung Cancer (Amsterdam, Netherlands)|March 17, 2022
Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancerArmando Santoro, Wu-Chou Su, Alejandro Navarro, et al.Carcinogenesis|December 15, 2012
EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking womenKuan-Yu Chen, Chin-Fu Hsiao, Gee-Chen Chang, et al.Plos One|September 24, 2021
Development of a novel ALK rearrangement screening test for non-small cell lung cancersYi-Lin Chen, Wan-Li Chen, Yi-Chia Cheng, et al.Frontiers in Oncology|August 6, 2019
Five Technologies for Detecting the EGFR T790M Mutation in the Circulating Cell-Free DNA of Patients With Non-small Cell Lung Cancer: A ComparisonYi-Lin Chen, Chien-Chung Lin, Shu-Ching Yang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 18, 2021
EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysisJeng-Shiuan Tsai, Po-Lan Su, Szu-Chun Yang, et al.Pageof 26